ArticleBiomedicines2023

Renal Disorders with Oral Tyrosine Kinase Inhibitors in Metastatic Colorectal Cancer: An Analysis from the FDA Adverse Event Reporting System Database.

Giulia Russo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.